Acromegaly Approved for Marketing Phase Trials for Pasireotide (DB06663)
Also known as: Acromegalic / Acromegaly (disorder)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0000951 (Acromegaly) | Approved for Marketing | Not Available |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT01995734 | An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly |